Goodwill and Other Intangible Assets, Net (Tables)

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Movements in Goodwill

Movements in goodwill attributable to each reportable segment for the nine months ended September 30, 2021 were as follows:

(DOLLARS IN MILLIONS)	Nourish		Health & Biosciences		Scent		Pharma Solutions		Total
Balance at December 31, 2020	$	4,859	$	—	$	734	$	—	$	5,593
Acquisitions(1)	2,702		6,651		910		1,539		11,802
Transferred to assets held for sale	(26)		(473)		—		—		(499)
Foreign exchange	(135)		(116)		(30)		(25)		(306)
Reallocation	(985)		728		257		—		—
Balance at September 30, 2021	$	6,415	$	6,790	$	1,871	$	1,514	$	16,590

_______________________ 

(1)Acquisitions relate to the Merger with N&B. The amount of goodwill, and allocation of goodwill among reporting units, from the Merger with the N&B Business is updated as of the third quarter of 2021 and may change in future periods as a result of purchase accounting being finalized. See Note 3 for additional information.

Schedule of Other Intangible Assets, Net

Other intangible assets, net consisted of the following amounts:

	September 30,		December 31,
(DOLLARS IN MILLIONS)	2021		2020
Asset Type
Customer relationships	$	9,203	$	2,728
Trade names & patents	387		187
Technological know-how	2,489		479
Other	51		38
Total carrying value	12,130		3,432
Accumulated Amortization
Customer relationships	(754)		(470)
Trade names & patents	(94)		(38)
Technological know-how	(288)		(168)
Other	(35)		(29)
Total accumulated amortization	(1,171)		(705)
Other intangible assets, net	$	10,959	$	2,727

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

Amortization expense for the next five years is expected to be as follows:

(DOLLARS IN MILLIONS)	2021		2022		2023		2024		2025
Estimated future intangible amortization expense	$	191	$	763	$	753	$	752	$	750